Search
- Gastrointestinal Immunocard STAT!® HpSA® Immunocard STAT!® Rotavirus Immunocard STAT!® EHEC Immunocard STAT!® E. coli O157 Plus Immunocard STAT!® CAMPY
- Parasitology Immunocard STAT!® Crypto/Giardia Controls Immunocard STAT!® Crypto/Giardia
- Pediatric & Neonatal Immunocard STAT!® MONO
- Respiratory Immunocard STAT!® Strep A Immunocard STAT!® Flu A&B Immunocard STAT!® Flu A&B Nasopharyngeal Wash/Aspirate Accessory Kit
- Sexual Health Immunocard STAT!® hCG
A CLIA waived one step lateral flow immunoassay for the direct detection of Group A Streptococcal antigens from throat swabs specimens.
NOTE: Actual product may vary from image displayed. Please refer to the package insert for complete information.
Catalog Number: 755250
Definitive answers, confidence in results results
Definitive answers, confidence in results results
Support & Documents
Downloadable PDFs
Webinars & Videos
FAQs
Yes, the recommendation is that negative results be confirmed with a more sensitive method like culture or a molecular test. Meridian offers two molecular options for Group A Strep testing, Alethia and Revogene. Both platforms offer rapid turn around times and definitive results without the subjectivity of culture.
Rapid tests can be used for near-patient testing, and are best when paired with a molecular test. Ask about Meridian’s Best of Both Worlds program and how your lab can provide same day results for better patient care.
1. Shulman et al. Clinical Practice Guideline for the Diagnosis and Management of Group A Streptococcal Pharyngitis:2012 Update by the Infectious Diseases Society of America
Immunocard STAT!® Strep A – 87880